Mainz Biomed (MYNZ) Payables (2020 - 2024)
Historic Payables for Mainz Biomed (MYNZ) over the last 5 years, with Q4 2024 value amounting to $2.3 million.
- Mainz Biomed's Payables fell 2792.77% to $2.3 million in Q4 2024 from the same period last year, while for Dec 2024 it was $2.3 million, marking a year-over-year decrease of 2792.77%. This contributed to the annual value of $2.3 million for FY2024, which is 2792.77% down from last year.
- According to the latest figures from Q4 2024, Mainz Biomed's Payables is $2.3 million, which was down 2792.77% from $3.2 million recorded in Q4 2023.
- Mainz Biomed's 5-year Payables high stood at $3.2 million for Q4 2023, and its period low was $423664.0 during Q4 2020.
- Over the past 5 years, Mainz Biomed's median Payables value was $2.3 million (recorded in 2024), while the average stood at $1.9 million.
- Its Payables has fluctuated over the past 5 years, first soared by 23648.72% in 2022, then tumbled by 2792.77% in 2024.
- Over the past 5 years, Mainz Biomed's Payables (Quarter) stood at $423664.0 in 2020, then soared by 90.61% to $807540.0 in 2021, then surged by 236.49% to $2.7 million in 2022, then increased by 17.19% to $3.2 million in 2023, then fell by 27.93% to $2.3 million in 2024.
- Its Payables stands at $2.3 million for Q4 2024, versus $3.2 million for Q4 2023 and $2.7 million for Q4 2022.